首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   508篇
  免费   30篇
  国内免费   5篇
耳鼻咽喉   11篇
儿科学   21篇
妇产科学   11篇
基础医学   49篇
口腔科学   10篇
临床医学   34篇
内科学   113篇
皮肤病学   3篇
神经病学   27篇
特种医学   29篇
外科学   39篇
综合类   7篇
预防医学   30篇
眼科学   25篇
药学   70篇
  1篇
中国医学   34篇
肿瘤学   29篇
  2023年   6篇
  2022年   5篇
  2021年   16篇
  2020年   12篇
  2019年   16篇
  2018年   25篇
  2017年   10篇
  2016年   23篇
  2015年   15篇
  2014年   21篇
  2013年   27篇
  2012年   42篇
  2011年   47篇
  2010年   26篇
  2009年   20篇
  2008年   29篇
  2007年   31篇
  2006年   27篇
  2005年   23篇
  2004年   17篇
  2003年   22篇
  2002年   15篇
  2001年   14篇
  2000年   3篇
  1999年   10篇
  1998年   2篇
  1997年   1篇
  1996年   3篇
  1995年   3篇
  1994年   1篇
  1993年   2篇
  1992年   2篇
  1991年   2篇
  1990年   4篇
  1989年   3篇
  1988年   2篇
  1987年   6篇
  1986年   2篇
  1985年   2篇
  1984年   1篇
  1983年   1篇
  1982年   2篇
  1981年   1篇
  1966年   1篇
排序方式: 共有543条查询结果,搜索用时 171 毫秒
131.
Exosomes are small membrane-bound vesicles that carry biological macromolecules from the site of production to target sites either in the microenvironment or at distant sites away from the origin. Exosomal content of cells varies with the cell type that produces them as well as environmental factors that alter the normal state of the cell such as viral infection. Human DNA and RNA viruses alter the composition of host proteins as well as incorporate their own viral proteins and other cargo into the secreted exosomes. While numerous viruses can infect various cell types of the CNS and elicit damaging neuropathologies, few have been studied for their exosomal composition, content, and function on recipient cells. Therefore, there is a pressing need to understand how DNA and RNA viral infections in CNS control exosomal release. Some of the more recent studies including HIV-1, HTLV-1, and EBV-infected B cells indicate that exosomes from these infections contain viral miRNAs, viral transactivators, and a host of cytokines that can control the course of infection. Finally, because exosomes can serve as vehicles for the cellular delivery of proteins and RNA and given that the blood-brain barrier is a formidable challenge in delivering therapeutics to the brain, exosomes may be able to serve as ideal vehicles to deliver protein or RNA-based therapeutics to the brain.  相似文献   
132.
133.
目的:利用Adeasy-1系统,构建并鉴定CARP基因重组腺病毒载体。方法:PCR扩增含有CARP全长cDNA的片段,经测序验证无误后,亚克隆至pAdTrack-CMV穿梭质粒,再与pAdEasy.1质粒在大肠杆菌BJ5 183中进行同源重组产生腺病毒载体质粒。经过抗性筛选以及酶切鉴定得到阳性的重组质粒,再在293细胞中进行包装扩增,利用Adeasy系统上的绿色荧光蛋白标签鉴定病毒表达。结果:测序证实PCR产物为CARP全长cDNA;抗性筛选及酶切鉴定均表明重组腺病毒载体构建成功;转染293细胞3天后可见绿色荧光,回收病毒可以重复感染293细胞,证明病毒包装成功。  相似文献   
134.
Preoperative localization is important for the successful treatment of gastrinomas. The aim of this study was to investigate whether selective intra-arterial calcium injection and hepatic venous sampling was able to localize gastrinomas in four patients who remained on proton pump inhibitor or H2 antagonist therapy. Calcium gluconate was injected directly into the arteries supplying the pancreas and liver after standard selective angiography. Gastrin levels were then measured in samples taken from the right hepatic vein. Calcium gluconate produced a diagnostic rise (at least 2-fold) in serum gastrin and unequivocally localized the tumour to a specific vascular territory in each case. One patient did not undergo surgery. In the remaining three patients, surgery confirmed the position and histology of the tumour. This study shows that in four patients with a confirmed gastrinoma we were able to localize the gastrinoma by selective intra-arterial calcium injection and hepatic venous sampling, whilst the patients remained on proton pump inhibitor or H2 antagonist therapy, thereby reducing their risk of gastrointestinal perforation.  相似文献   
135.

Objectives

This study sought to evaluate the safety, feasibility, and outcomes of transcatheter pulmonary valve replacement (TPVR) in conduits ≤16 mm in diameter.

Background

The Melody valve (Medtronic, Minneapolis, Minnesota) is approved for the treatment of dysfunctional right ventricular outflow tract (RVOT) conduits ≥16 mm in diameter at the time of implant. Limited data are available regarding the use of this device in smaller conduits.

Methods

The study retrospectively evaluated patients from 9 centers who underwent percutaneous TPVR into a conduit that was ≤16 mm in diameter at the time of implant, and reported procedural characteristics and outcomes.

Results

A total of 140 patients were included and 117 patients (78%; median age and weight 11 years of age and 35 kg, respectively) underwent successful TPVR. The median original conduit diameter was 15 (range: 9 to 16) mm, and the median narrowest conduit diameter was 11 (range: 4 to 23) mm. Conduits were enlarged to a median diameter of 19 mm (29% larger than the implanted diameter), with no difference between conduits. There was significant hemodynamic improvement post-implant, with a residual peak RVOT pressure gradient of 7 mm Hg (p < 0.001) and no significant pulmonary regurgitation. During a median follow-up of 2.0 years, freedom from RVOT reintervention was 97% and 89% at 2 and 4 years, respectively, and there were no deaths and 5 cases of endocarditis (incidence rate 2.0% per patient-year).

Conclusions

In this preliminary experience, TPVR with the Melody valve into expandable small diameter conduits was feasible and safe, with favorable early and long-term procedural and hemodynamic outcomes.  相似文献   
136.
137.
138.
Organic photovoltaics (OPVs) die due to their interactions with environmental gases, i.e., moisture and oxygen, the latter being the most dangerous, especially under illumination, due to the fact that most of the active layers used in OPVs are extremely sensitive to oxygen. In this work we demonstrate solution-based effective barrier coatings based on composite of poly(vinyl butyral) (PVB) and mica flakes for the protection of poly (3-hexylthiophene) (P3HT)-based organic solar cells (OSCs) against photobleaching under illumination conditions. In the first step we developed a protective layer with cost effective and environmentally friendly methods and optimized its properties in terms of transparency, barrier improvement factor, and bendability. The developed protective layer maintained a high transparency in the visible region and improved oxygen and moisture barrier quality by the factor of ~7. The resultant protective layers showed ultra-flexibility, as no significant degradation in protective characteristics were observed after 10 K bending cycles. In the second step, a PVB/mica composite layer was applied on top of the P3HT film and subjected to photo-degradation. The P3HT films coated with PVB/mica composite showed improved stability under constant light irradiation and exhibited a loss of <20% of the initial optical density over the period of 150 h. Finally, optimized barrier layers were used as encapsulation for organic solar cell (OSC) devices. The lifetime results confirmed that the stability of the OSCs was extended from few hours to over 240 h in a sun test (65 °C, ambient RH%) which corresponds to an enhanced lifetime by a factor of 9 compared to devices encapsulated with pristine PVB.  相似文献   
139.
Although double-balloon enteroscopy (DBE) is useful for the diagnosis and management of patients with obscure gastrointestinal bleeding, the technique is fairly invasive, has several limitations, and can be associated with complications. It is, therefore, important to identify those patients who will benefit most from DBE, and those in whom the procedure should be avoided. In this Practice Point commentary, we discuss the findings and limitations of a retrospective study conducted by Hendel and colleagues that evaluated the utility of capsule endoscopy screening for the selection of patients with obscure gastrointestinal bleeding who would benefit from DBE. The results suggest that capsule endoscopy screening is useful to predict the diagnostic yield of DBE, guide the route of DBE, influence sedation choices, and avoid the performance of unnecessary procedures. This commentary highlights the issues to consider when interpreting and generalizing these results in clinical practice.  相似文献   
140.

Introduction

Cardiac rehabilitation improves disease-related symptoms, quality of life, and clinical outcomes. This study was done to evaluate the effect of cardiac rehabilitation program on cardiovascular risk factors in chronic heart failure patients as well as functional capacity and health related quality of life.

Methods

The study was conducted on 80 Patients with chronic stable heart failure. All patients had full history and thorough physical examination. Body mass index (BMI), waist circumference, glycated hemoglobin (HbA1c), lipid profile, and echocardiography, all of which were done before and after recruitment in a 2?months cardiac rehabilitation program (through prescribed exercise training, 2 sessions/week for 2?months). The changes in functional capacity were evaluated by 6-min walk test (6MWT) and the changes in the health related quality of life were measured by Minnesota living with heart failure questionnaire (MLHFQ), both were done before and after the rehabilitation program.

Results

There was a highly significant reduction in the blood pressure, heart rate, BMI, waist circumference, the smokers’ number and the glycated hemoglobin (HbA1c) (P?<?0.01). However, there was no statistically significant reductions in low density lipoproteins (LDL), Triglycerides (P?>?0.05). Highly significant improvements were noted in the functional capacity and the health related quality of life as evidenced by improvement in the 6MWT and the MLHFQ scores (total score, physical and psychological domains, P?<?0.01).

Conclusion

Cardiac rehabilitation had a significant improvement of cardiovascular risk factors, functional capacity and Health related quality of life in patients with chronic heart failure.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号